["Other circumstances": on the contribution by L. A. Hoffmann, T. Kümpfel, I. Heer et al. (2006) "Other circumstances": Pregnancy and immunomodulatory therapy in multiple sclerosis. Nervenarzt 77: 663-670].
Schröder
S
S
Schilli
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000075202:Contraindications; D017277:Drug Approval; D005260:Female; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011261:Pregnancy Trimester, First; D011358:Product Surveillance, Postmarketing
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta